Metraipolis › archive › dc_5f1a29d390db

Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities — Europe PMC PMID:42794978

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794978
DOI
10.3390/cancers18183011
License (as archived)
solo-consultazione
Archived
2026-10-09T06:27:02.153Z
SHA-256 of the archived text
010bec8d13321fbba4552adc545dce14f79c7184bda3378af583e7fe54768b5d
Stable URL of this page
https://metraipolis.com/documento/dc_5f1a29d390db

How to cite

Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities — Europe PMC PMID:42794978 — Europe PMC (en), https://europepmc.org/article/MED/42794978 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f1a29d390db (Metraipolis archive dc_5f1a29d390db, sha256 010bec8d13321fbba4552adc545dce14f79c7184bda3378af583e7fe54768b5d)
BibTeX
@misc{dc5f1a29d390db,
  title = {Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities — Europe PMC PMID:42794978},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794978},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f1a29d390db; sha256 010bec8d13321fbba4552adc545dce14f79c7184bda3378af583e7fe54768b5d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794978. Agents can read the archived copy with the MCP tool read_document.